[1] |
Schrauzer GN. Selenium and cancer. In: Selenium in medicine and biologylNeve J and Favier A eds)Berlin. New York:Walter de Gruyter e, Co, 1988:251
|
[2] |
刘新光,于树玉。亚硒酸钠和维甲酸联合对HL-60细胞生长、分化的影响。肿瘤防治研究,1996 23:209
|
[3] |
Brooks SC, Kazmer S, Levin AA,et al. Myeloid differen-tiation and retinoblastoma phosphorylation changes in HI_-60 cells induced by retinoic acid receptor-and retinoid X re-ceptor-selective retinoic acid analogs. Blood,1996,87:227
|
[4] |
Sellers WR, Kaelin WG. RB as a modulator of transcrip-tion. Biochim Biophys Acta, 1996,]288: MI
|
[5] |
Chen PL,Scully P, Shew JY, et al. Phosphorylation ofthe retinoblastoma gene product is modulated during thecell cycle and cellular differentiation. Cel1,1989,58:1193
|
[6] |
Mihara K, Cao XR, Yen A, et al. Cell cycle-dependentregulation of phosphorylation of the human retinoblastomagene product. Science,1989,246:1300
|
[7] |
Lowry OH,Rosebrough NJ,Farr AI,et al. Protein measurement with the Folin phenol reagent. J Biol C hem,1951,193:265
|
[8] |
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T,. Natrue, 1977,227:680
|
[9] |
Jing YK, Hashimoto S, Nakajo S, et al. Topoisomerase in-hibitors potentiate the effect of retinoic acid on cell growth inhibition and induction of differentiation of leukemia HI 60 cells. Leukemia Res,1991, 18:299
|
[10] |
Chen PL,Riley DJ,Lee WH. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit Rev Fukaryot Gene. Fxpr,1995。5:79
|
[11] |
Weinberg RA. The retinoblastoma protein and cell cycle control. Cell,1995,81:323
|
[12] |
Linppman SM,Kessler JF,Meskens FL Jr. Retinoids as preventuve and therapeutic anticancer agents (Partl).Cancer Treat Rep,1987,71:391
|